Tissue factor activity of cultured human vascular cells

  • James R. Maynard
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 27)

Abstract

Blood coagulation can be initiated by either the intrinsic or extrinsic coagulation pathways. Both pathways involve the sequential activation of proenzymes which circulate in plasma. The initial event in both pathways is the interaction of specific proteolytic zymogens with noncirculating constituents of the blood vessel wall.

Keywords

Smooth Muscle Cell Tissue Factor Tissue Factor Activity Normal Cell Type Extrinsic Coagulation Pathway 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Niewiarowski, S., Bankowski, E. and Fiedoruk, T. 1964. Adsorption of Hageman factor (factor XII) on collagen. Experientia 20: 367–368.PubMedCrossRefGoogle Scholar
  2. 2.
    Wuepper, K.D. 1973. Prekallikrein deficiency in man. J. Exp. Med. 138: 1345–1355.PubMedCrossRefGoogle Scholar
  3. 3.
    Saito, H., Ratnoff, O.D., Waldman, R. and Abraham, J.P. 1975. Fitzgerald trait: Deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability. J. Clin. Invest. 55: 1082–1089.PubMedCrossRefGoogle Scholar
  4. 4.
    Wiggins, R.C., Loskutoff, D.J., Cochrane, C.G., Griffin, J.H. and Edgington, T.S. 1980. Activation of rabbit Hage-man factor by homogenates of cultured rabbit endothelial cells. J. Clin. Invest 65: 197–206.PubMedCrossRefGoogle Scholar
  5. 5.
    Bach, R., Nemerson, Y. and Konigsberg, W.H. 1981. Purification and characterization of bovine tissue factor. J. Biol. Chem. 256: 8324–8331.PubMedGoogle Scholar
  6. 6.
    Nemerson, Y. 1968. The phospholipid requirement of tissue factor in blood coagulation. J. Clin. Invest. 47: 72–80.PubMedCrossRefGoogle Scholar
  7. 7.
    Silverberg, S.A., Nemerson, Y. and Zur, M. 1977. Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. J. Biol. Chem. 252: 8481–8488.PubMedGoogle Scholar
  8. 8.
    Gonmori, H. and Takeda, Y. 1976. Properties of human tissue thromboplastins from brain, lung, arteries, and placenta. Thrombos. Haemostas. (Stuttg) 36: 90–103.Google Scholar
  9. 9.
    Zeldis, S.M., Nemerson, Y., Pitlick, F.A. and Lentz, T.L. 1972. Tissue factor (thromboplastin): Localization to the plasma membranes by peroxidase-conjugated antibodies. Science 175: 766–768.PubMedCrossRefGoogle Scholar
  10. 10.
    Neimetz, J. 1972. Coagulation activity of leukocytes: Tissue factor activity. J. Clin. Invest. 51: 307–313.CrossRefGoogle Scholar
  11. 11.
    Edwards, R.L., Rickles, F.R. and Bobrove, A.M. 1979. Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood 54: 359–370.PubMedGoogle Scholar
  12. 12.
    Rothberger, H., Zimmerman, T.S. and Vaughan, J.H. 1978. Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes. J. Clin. Invest. 62: 649–655.PubMedCrossRefGoogle Scholar
  13. 13.
    Muhlfelder, T.W., Niemetz, J., Kreutzer, D., Beebe, D., Ward, P.A. and Rosenfeld, S.I. 1979. C5 chemotactic fragment induces leukocyte production of tissue factor, a link between complement and coagulation. J. Clin. Invest. 63: 147–150.PubMedCrossRefGoogle Scholar
  14. 14.
    Rickles, F.R., Levin, J., Hardin, J.A., Barr, C.F. and Conrad, M.E. Jr. 1977. Tissue factor generation by human mononuclear cells: Effects of endotoxin and dissociation of tissue factor generation from mitogenic response. J. Lab. Clin. Med. 89: 792–803.PubMedGoogle Scholar
  15. 15.
    Zacharski, L.R., Bowie, E.J.W., Titus, J.L. and Owen, C.A. 1969. Cell-culture synthesis of a factor VIII-like activity. Mayo Clin. Proc. 44: 784–792.PubMedGoogle Scholar
  16. 16.
    Green, D., Ryan, C., Malandruccolo, N. and Nadler, H.L. 1971. Characterization of the coagulant activity of cultured human fibroblasts. Blood J. Hematol. 37: 47–51.Google Scholar
  17. 17.
    Jaffe, E.A., Nachman, R.L., Becker, C.G. and Minick, C.R. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52: 2745–2756.PubMedCrossRefGoogle Scholar
  18. 18.
    Maynard, J.R., Dreyer, B.E., Stemerman, M.B. and Pitlick, F.A. 1977. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood 50: 387–395.PubMedGoogle Scholar
  19. 19.
    Maynard, J.R., Heckman, C.A., Pitlick, F.A. and Nemerson, Y. 1975. Association of tissue factor activity with the surface of cultured cells. J. Clin. Invest. 55: 814–824.PubMedCrossRefGoogle Scholar
  20. 20.
    Maynard, J.R., Burkholder, D.E. and Pizzuti, D.J. 1978. Comparative pharmacologic effects on tissue factor activity in normal cells and an established cell line. Lab. Invest. 38: 14–20.PubMedGoogle Scholar
  21. 21.
    Ross, R. and Vogel, A. 1978. The platelet-derived growth factor. Cell 14: 203–210.PubMedCrossRefGoogle Scholar
  22. 22.
    Smariga, P.E. and Maynard, J.R. 1982. Platelet effects on tissue factor and fibrinolytic inhibition of cultured human fibroblasts and vascular cells. Blood 60: 140–147.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1984

Authors and Affiliations

  • James R. Maynard

There are no affiliations available

Personalised recommendations